i3 Buys CRO ChinaGate
i3’s customers are expected to benefit from ChinaGate’s expertise in overseeing clinical trials, submitting filings, obtaining licenses and navigating the regulatory process. ChinaGate’s customers will gain access to
Amberstone Biosciences has signed a partnership and licence agreement with Shanghai Henlius Biotech for conditionally activated T-cell engager candidates to treat solid tumours.
Cinryze is a highly purified, pasteurised and nanofiltered plasma-derived C1 esterase inhibitor product that has been approved by FDA in October 2008 for routine prophylaxis against hereditary angioedema(HAE)